1. Home
  2. ADP vs VRTX Comparison

ADP vs VRTX Comparison

Compare ADP & VRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Automatic Data Processing Inc.

ADP

Automatic Data Processing Inc.

HOLD

Current Price

$266.13

Market Cap

102.9B

Sector

Technology

ML Signal

HOLD

Logo Vertex Pharmaceuticals Incorporated

VRTX

Vertex Pharmaceuticals Incorporated

HOLD

Current Price

$452.76

Market Cap

96.6B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
ADP
VRTX
Founded
1949
1989
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
EDP Services
Sector
Technology
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
102.9B
96.6B
IPO Year
N/A
1991

Fundamental Metrics

Financial Performance
Metric
ADP
VRTX
Price
$266.13
$452.76
Analyst Decision
Hold
Buy
Analyst Count
12
25
Target Price
$312.25
$494.64
AVG Volume (30 Days)
2.2M
1.4M
Earning Date
01-28-2026
11-03-2025
Dividend Yield
2.56%
N/A
EPS Growth
8.22
N/A
EPS
10.13
14.22
Revenue
$20,903,400,000.00
$11,723,300,000.00
Revenue This Year
$6.88
$11.01
Revenue Next Year
$5.78
$8.74
P/E Ratio
$26.27
$31.78
Revenue Growth
7.07
10.33
52 Week Low
$247.18
$362.50
52 Week High
$329.93
$519.68

Technical Indicators

Market Signals
Indicator
ADP
VRTX
Relative Strength Index (RSI) 59.91 59.92
Support Level $256.83 $433.81
Resistance Level $262.76 $463.85
Average True Range (ATR) 4.12 10.71
MACD 2.04 0.51
Stochastic Oscillator 98.78 72.53

Price Performance

Historical Comparison
ADP
VRTX

About ADP Automatic Data Processing Inc.

Automatic Data Processing is a global technology company providing cloud-based human capital management solutions, enabling clients to better implement payroll, talent, time, tax, and benefits administration. Additionally, ADP provides human resource outsourcing solutions that permit customers to offload some of their traditional HR tasks. The company operates through two segments: employer services and professional employer organization services. Employer services consist of the company's HCM products as well as a la carte HRO solutions. PEO services contain ADP's comprehensive HRO solution, where it acts as a co-employer with its customer. As of fiscal 2025, ADP serves over 1.1 million clients and pays over 42 million workers across 140 countries.

About VRTX Vertex Pharmaceuticals Incorporated

Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio, and Alyftrek for cystic fibrosis, where Vertex therapies remain the standard of care globally. Vertex has diversified its portfolio through Casgevy, a gene-editing therapy for beta thalassemia and sickle-cell disease, and Journavx, a non-opioid pain medication approved for the treatment of moderate-to-severe acute pain in adults. Additionally, Vertex is evaluating small-molecule inhibitors of APOL1-mediated kidney diseases. Vertex is also investigating cell therapies to deliver a potential functional cure for type 1 diabetes.

Share on Social Networks: